Ternary Ti—Zr—O alloys, methods for producing same and associated utilizations thereof

US11542583B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11542583-B2
Application numberUS-202117197633-A
CountryUS
Kind codeB2
Filing dateMar 10, 2021
Priority dateNov 22, 2017
Publication dateJan 3, 2023
Grant dateJan 3, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to the use of a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy, characterized in that it comprises from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with said alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution of Hexagonal Close Packed (HCP) structure at room temperature in the medical, transport or energy fields.

First claim

Opening claim text (preview).

The invention claimed is: 1. A product comprising a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being a single-phase material consisting of a stable and homogeneous α solid solution with a Hexagonal Close Packed (HCP) structure at room temperature. 2. The product according to claim 1 wherein the product is a medical device. 3. The product according to claim 1 wherein the product is a medical device, said medical device being an orthopedic implant. 4. The product according to claim 1 wherein the product is a component for medical applications or dental applications. 5. The product according to claim 1 wherein the product is a component for aerospace applications, nuclear applications, energy applications, chemical processing applications or transportation applications. 6. A ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous a solid solution with a Hexagonal Close Packed (HCP) structure at room temperature, said alloy being in the form of a powder. 7. A product comprising a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy comprising from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with the alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution with a Hexagonal Close Packed (HCP) structure at room temperature, wherein the product is a medical device, the medical device being a dental implant.

Assignees

Inventors

Classifications

  • C22C14/00Primary

    Alloys based on titanium · CPC title

  • C22F1/183Primary

    of titanium or alloys based thereon · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11542583B2 cover?
The invention relates to the use of a ternary Titanium-Zirconium-Oxygen (Ti—Zr—O) alloy, characterized in that it comprises from 83% to 95.15 mass % of titanium, from 4.5% to 15 mass % of zirconium and from 0.35% to 2 mass % of oxygen, with said alloy being capable of forming a single-phase material consisting of a stable and homogeneous α solid solution of Hexagonal Close Packed (HCP) structur…
Who is the assignee on this patent?
Paris Sciences Lettres Quartier Latin, Centre Nat Rech Scient, Biotech Dental, and 2 more
What technology area does this patent fall under?
Primary CPC classification C22C14/00. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).